[1]
Y. Fang, “Advances in the Clinical Application of Novel PCSK9 Inhibitors for High-Risk Atherosclerotic Cardiovascular Disease”, IJBLS, vol. 16, no. 1, pp. 15–25, Aug. 2026, doi: 10.54097/wp0rhk16.